


Virdante Pharmaceuticals
Biotechnology Research • United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +16173008500 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
Key Contact at Virdante Pharmaceuticals
Kalyan Anumula
Director, Analytical Development
About Virdante Pharmaceuticals
Virdante is a privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. Our products incorporate a proprietary "sialic switch" technology to improve the anti-inflammatory properties of antibodies.
Virdante Pharmaceuticals revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | $30,100,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Explore Virdante Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Virdante Pharmaceuticals Tech Stack
Discover the technologies and tools that power Virdante Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Hosting
Frequently asked questions
4.8
40,000 users



